Finnish researchers developing nasal COVID-19 vaccine
March 8th 2021Investigators at Rokote Laboratories Finland Ltd. say they selected the nasal route of delivery because the virus is transmitted through the airways, and they claim that nasal administration may induce a wider immune response than intramuscular administration.
Read More
Survey shows primary care is willing to distribute COVID-19 vaccines widely and equitably
February 24th 2021According to a survey by the Larry A. Green Center, in collaboration with the Primary Care Collaborative (PCC) and 3rd Conversation, primary care offers assets, including experience and relationships with patients.
Read More
A light at the end of the COVID-19 tunnel? Continued vigilance is mandatory
February 22nd 2021The American Medical Association, American Hospital Association, American Nurses Association issued a sobering reality check as COVID-19 deaths in the United States passed the grim 500,000 milestone.
Read More
Biophytis expands patient recruitment for part 2 of COVA Study in France, Belgium
February 17th 2021Biophytis will begin recruiting patients in France and Belgium for the second part of the COVA Study analyzing its leading drug candidate as a potential treatment for acute respiratory failure linked to COVID-19.
Read More
SARS-CoV-2 genomic RNA in corneal transplantation: Are corneal transplantations safe?
January 27th 2021According to investigators, a lack of definitive knowledge about the presence of SARS-CoV-2 in corneal tissues has resulted in the recommendation to avoid using corneal tissue for transplantation when the tissue was obtained from donors with COVID-19 that had been confirmed or those who were exposed to COVID-19.
Read More